Effects of high dose vitamin D supplementation on muscle mass and muscle strength in frail elderly people

ISRCTN ISRCTN33988275
DOI https://doi.org/10.1186/ISRCTN33988275
Secondary identifying numbers 2007-160
Submission date
11/04/2007
Registration date
11/04/2007
Last edited
07/04/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr C Oudshoorn
Scientific

Erasmus Medical Centre
Room D442
P.O. Box 2040
Rotterdam
3000 CA
Netherlands

Phone +31 (0)10 463 5037
Email c.oudshoorn@erasmusmc.nl

Study information

Study designRandomised placebo controlled parallel group double blind trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeQuality of life
Participant information sheet Copies of the Investigational Medicinal Product Dossier (IMPD) and 2007 MEC approval are available on request. Please use contact details below.
Scientific title
Study objectivesVitamin D improves muscle-mass and -strength which improves overall quality of life in patients with low serum vitamin D levels.

Please note that as of 13/07/10 this record was updated to included changes made to the protocol during the planning phase of the trial (i.e. between the time of registration and the beginning of the recruitment phase). All updates can be found in the relevant field with the above update date.
Ethics approval(s)Added 13/07/10:
The Medical Ethics Review Committee (Medisch Ethische Toetsings Commissie), Erasmus Medical Centre approved on the 24th of July 2007 (ref: MEC-2007-160)
Health condition(s) or problem(s) studiedHypovitaminosis D on muscle mass and strength
InterventionCurrent information as of 13/07/10:
Patients were randomised to receive either
1. 1800IU cholecalciferol (vitamin D3) daily
2. Placebo daily
Medications were used for a period of six months. The end date for inclusion into this trial was December 2009.

Initial information at time of registration
Individuals are randomised to recieve either:
1. 1200 IU vitamin D/day and 1000 mg calcium/day
2. Placebo medications and 1000 mg calcium/day

Medications will be used for a period of six months.
Intervention typeSupplement
Primary outcome measureDifferences in muscle strength (handgrip strength and quadriceps strength) between treatment and control group.
Secondary outcome measures1. Changes in mobility:
1.1. Timed up and go test
1.2. Walking distance
2. Quality of life (using the health assessment questionnaire)
3. Falls
Overall study start date01/04/2007
Completion date01/04/2008

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants300
Key inclusion criteria1. Frail elderly people, aged greater than 65 years
2. Living in homes for the elderly
3. Serum vitamin D level less than 50 nmol/l
Added 07/04/2011:
4: Stable health (including no history of recurrent falling or recent fracture).
Key exclusion criteria1. Not able to perform muscle strength measurements
2. History of kidney stones, renal insufficiency (less than 40%)
3. Primary hyperparathyroidism
4. Dementia (Mini Mental State Examination [MMSE] less than 20/30 points
5. Life expectancy less than six months
6. Neurodegenerative disorders (Parkinsons, Amyotrophic Lateral Sclerosis [ALS])
7. Use of the following medications:
7.1. Vitamin D
7.2. Bisphosphonates
7.3. Steroids
Date of first enrolment01/04/2007
Date of final enrolment01/04/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Erasmus Medical Centre
Rotterdam
3000 CA
Netherlands

Sponsor information

Erasmus Medical Centre (Netherlands)
Hospital/treatment centre

Department of Geriatrics
P.O. Box 2040
Rotterdam
3000 CA
Netherlands

Website http://www.erasmusmc.nl/
ROR logo "ROR" https://ror.org/018906e22

Funders

Funder type

Hospital/treatment centre

Erasmus Medical Centre (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan